Future of Pain: now accepting applications for our Challenge led programme in partnership with GSK Consumer Healthcare
The MedTech SuperConnector is set up and designed to facilitate the early stage development of innovative medical technologies, from devices, diagnostics, and digital healthcare solutions. MTSC will provide participants with the funding, training, mentorship and access to industry partners to help fast-track the translation of their research discoveries.See how it works
Dive into the programme and hear more from the first cohort.
How we are funded
Funded by Research England, MedTech SuperConnector (MTSC) is an initiative from a consortium of eight dynamic London universities with interest in nurturing talent, ideas, and entrepreneurship. MTSC will focus uniquely on a new route for Post-Docs and graduate students, to translate medtech discoveries from academic labs into startup companies, proposing more solutions to today’s health challenges.
Connecting Capabilities: Impacts from Cohorts One & Two of the MedTech SuperConnector accelerator programmes
MedTech SuperConnector (MTSC) runs alternating eight and six-month accelerator programmes and…
On target: A clever catheter to track and treat brain diseases
Cohort Three participant Riccardo Secoli recent feature by Imperial College…
Newsletter: Accepting applications for Cohort Four in partnership with GSK NEXT & Beyond teams
MedTech SuperConnector Newsletter March 2020 We’re pleased to announce that…
Future of Pain, applications for Cohort Four in partnership with GSK Consumer Healthcare NEXT & Beyond
We have partnered with GSK Consumer Healthcare Next & Beyond…
Collaborating to collaborate
Research England has released its first report highlighting the learnings and successes of the Connecting Capability Fund (CCF) projects.